The microarchitecture of fossil pterosaur bones could hold the key to lighter, stronger materials for the next generation of ...

A new FDA-approved blood test is helping doctors in Texas detect colon cancer earlier. ‘The whole island has emptied:’ ...

CAPE CANAVERAL, Fla. (AP) — New research finds an ancient asteroid strike carved out two grand canyons on the moon's far side. These aren’t the magnets you know.

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...

This unique degree programme offers training in an unparalleled range of ancient languages and their associated history, culture and textual traditions. Students study Hebrew and either Greek or Latin ...

A local government in India is offering a $1 million prize to the first person who cracks the code of an ancient script found in the ruins of one of the world’s earliest civilizations.

The synthetic chromosome includes features that enable researchers to generate genetic diversity on demand, accelerating the development of yeasts with enhanced capabilities for biotechnology ...

But the citrus genus has a surprising history, popping up everywhere from ancient Rome and the Renaissance to naval exploration and Casanova's famed romantic trysts. The history of citrus dates ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...